PAPER
Fluorinated Heterocycles
MS (ESI): m/z = 433/435 [M + H]+.
1689
study may be considered as valuable synthons for further
elaboration into more complex heterocycles of biological
relevance.
Anal. Calcd for C19H16ClF3O6: C, 52.73; H, 3.73. Found: C, 52.52;
H, 3.71.
Ethyl 4-(4-Bromophenyl)-2-hydroxy-7-methyl-5-oxo-2-(trifluo-
romethyl)-3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-3-carboxyl-
ate (4d)
Melting points were measured in Melt-Temp apparatus and were
1
uncorrected. H and 19F NMR spectra were recorded in CDCl3
White solid; yield: 372.0 mg (78%); mp 229–230 °C.
Bruker AM-500 instruments with TMS and CFCl3 (with upfield
negative) as the internal and external standards, respectively. IR
spectra were obtained with a Nicolet AV-360 spectrophotometer.
LR-MS were determined with Agilent 1100 LC/MSD SL instru-
ment using ESI technique. HRMS were run on Bruker Daltonics,
Inc. APEXIII 7.0 Tesla FTMS using ESI technique. Elemental anal-
yses were performed using a Vario EL III analyzer. All the solvents
were not purified before use. X-ray diffraction crystal structure
analysis was obtained on Bruker P4 instrument using graphite
monochromatized MoKα radiation (λ = 0.71073 Å) at 293(2) K.
IR (KBr): 3427, 3064, 2808, 1741, 1680, 1015, 997, 815 cm–1.
1H NMR (500 MHz, CDCl3): δ = 1.05 (t, J = 7.0 Hz, 3 H), 2.24 (s,
3 H), 3.02 (d, J = 12.0 Hz, 1 H), 4.06 (d, J = 12.0 Hz, 1 H), 4.06 (qd,
J1 = 7.0 Hz, 2J2 = 11.5 Hz, 2 H), 5.60 (s, 1 H), 5.96 (s, 1 H), 7.03 (d,
J = 8.5 Hz, 2 H), 7.10 (d, J = 8.5 Hz, 2 H).
19F NMR (470 MHz, CDCl3): δ = –84.05 (s, 3 F).
MS (ESI): m/z = 477/479 [M + H]+.
Anal. Calcd for C19H16BrF3O6: C, 47.82; H, 3.38. Found: C, 47.87;
H, 3.23.
Ethyl 2-Hydroxy-7-methyl-5-oxo-4-phenyl-2-(trifluoromethyl)-
3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-3-carboxylate (4a);
Typical Procedure
Ethyl 2-Hydroxy-7-methyl-4-(4-nitrophenyl)-5-oxo-2-(trifluo-
romethyl)-3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-3-carboxyl-
ate (4e)
To a mixture of benzaldehyde (1a, 106.0 mg, 1.0 mmol), 4-hy-
droxy-6-methyl-3,4-dihydro-2H-pyran-2-one (2, 126.0 mg, 1.0
mmol), and ethyl trifluoroacetoacetate (3, 184.0 mg, 1.0 mmol) in
EtOH (15 mL) was added NH4OAc (77.1 mg, 1.0 mmol). The resul-
tant mixture was stirred at reflux temperature for the time indicated
(Table 2). After completion of the reaction, the solvent was evapo-
rated and the residue was purified by column chromatography (sil-
ica gel, petroleum ether–EtOAc, 4:1) to afford pure 4a as a white
solid; yield: 279.0 mg (70%); mp 219–220 °C.
White solid; yield: 360.0 mg (81%); mp 233–234 °C.
IR (KBr): 3431, 3110, 3080, 2987, 2941, 1736, 1679, 1585, 1018,
995, 816 cm–1.
1H NMR (500 MHz, CDCl3): δ = 1.03 (t, J = 7.5 Hz, 3 H), 2.26 (s,
3 H), 3.05 (d, J = 11.5 Hz, 1 H), 4.07 (qd, J1 = 7.0 Hz, 2J2 = 13.5 Hz,
2 H), 4.24 (d, J = 11.5 Hz, 1 H), 5.52 (s, 1 H), 6.01 (s, 1 H), 7.34 (d,
J = 8.5 Hz, 2 H), 8.18 (d, J = 8.5 Hz, 2 H).
IR (KBr): 3434, 3067, 2984, 2939, 1740, 1680, 1017, 736, 715
cm–1.
1H NMR (500 MHz, CDCl3): δ = 1.01 (t, J = 7.0 Hz, 3 H), 2.26 (s,
3 H), 3.10 (d, J = 11.5 Hz, 1 H), 4.07 (q, J = 7.0 Hz, 2 H), 4.12 (d,
J = 11.5 Hz, 1 H), 5.68 (s, 1 H), 5.99 (s, 1 H), 7.12–7.36 (m, 5 H).
19F NMR (470 MHz, CDCl3): δ = –83.92 (s, 3 F).
MS (ESI): m/z = 444 [M + H]+.
Anal. Calcd for C19H16F3NO8: C, 51.48; H, 3.64; N, 3.16. Found: C,
51.48; H, 3.27, N, 3.31.
19F NMR (470 MHz, CDCl3): δ = –84.13 (s, 3 F).
MS (ESI): m/z = 399 [M + H]+.
Ethyl 4-(4-Cyanophenyl)-2-hydroxy-7-methyl-5-oxo-2-(trifluo-
romethyl)-3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-3-carboxyl-
ate (4f)
Anal. Calcd for C19H17F3O6: C, 57.29; H, 4.30. Found: C, 57.21; H,
4.28.
White solid; yield: 293.0 mg (69%); mp 226–227 °C.
IR (KBr): 3410, 3072, 2989, 2941, 2849, 1736, 1680, 1018, 995,
817 cm–1.
1H NMR (500 MHz, CDCl3): δ = 0.88 (t, J = 7.0 Hz, 3 H), 2.26 (s,
3 H), 3.03 (d, J = 11.5 Hz, 1 H), 4.07 (qd, J1 = 7.0 Hz, 2J2 = 16.0 Hz,
2 H), 4.18 (d, J = 11.5 Hz, 1 H), 5.54 (s, 1 H), 6.00 (s, 1 H), 7.28 (d,
J = 8.5 Hz, 2 H), 7.62 (d, J = 8.5 Hz, 2 H).
Ethyl 2-Hydroxy-7-methyl-5-oxo-4-p-tolyl-2-(trifluoromethyl)-
3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-3-carboxylate (4b)
White solid; yield: 260.0 mg (63%); mp 222–223 °C.
IR (KBr): 3427, 3033, 2981, 2925, 2868, 1744, 1680, 1021, 996,
814 cm–1.
19F NMR (470 MHz, CDCl3): δ = –83.93 (s, 3 F).
MS (ESI): m/z = 424 [M + H]+.
1H NMR (500 MHz, CDCl3): δ = 1.02 (t, J = 7.0 Hz, 3 H), 2.23 (s,
3 H), 2.30 (s, 3 H), 3.05 (d, J = 11.5 Hz, 1 H), 4.06 (qd, J1 = 7.0 Hz,
2J2 = 11.0 Hz, 2 H), 4.09 (d, J = 11.5 Hz, 1 H), 5.64 (s, 1 H), 5.96
(s, 1 H), 7.01 (d, J = 8.0 Hz, 2 H), 7.10 (d, J = 8.0 Hz, 2 H).
19F NMR (470 MHz, CDCl3): δ = –80.66 (s, 3 F).
MS (ESI): m/z = 413 [M + H]+.
Anal. Calcd for C20H16F3NO6: C, 56.74; H, 3.81; N, 3.31. Found: C,
56.73; H, 3.82; N, 3.35.
Ethyl 2-Hydroxy-4-(4-methoxyphenyl)-7-methyl-5-oxo-2-(tri-
fluoromethyl)-3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-3-car-
boxylate (4g)
Anal. Calcd for C20H19F3O6: C, 58.25; H, 4.64. Found: C, 58.19; H,
4.49.
White solid; yield: 262.0 mg (61%); mp 206–207 °C.
IR (KBr): 3437, 3002, 2938, 1742, 1681, 1375, 1018, 959, 821
cm–1.
1H NMR (500 MHz, CDCl3): δ = 1.04 (t, J = 7.0 Hz, 3 H), 2.23 (s,
3 H), 3.05 (d, J = 11.5 Hz, 1 H), 3.78 (s, 3 H), 4.06 (q, J = 7.0 Hz, 2
H), 4.07 (d, J = 11.5 Hz, 1 H), 5.63 (s, 1 H), 5.96 (s, 1 H), 6.84 (d,
J = 6.5 Hz, 2 H), 7.06 (d, J = 6.5 Hz, 2 H).
Ethyl 4-(4-Chlorophenyl)-2-hydroxy-7-methyl-5-oxo-2-(trifluo-
romethyl)-3,4-dihydro-2H,5H-pyrano[4,3-b]pyran-3-carboxyl-
ate (4c)
White solid; yield: 329.0 mg (76%); mp 216–217 °C.
IR (KBr): 3434, 3067, 3005, 2939, 1740, 1680, 1017, 995, 814
cm–1.
19F NMR (470 MHz, CDCl3): δ = –84.15 (s, 3 F).
MS (ESI): m/z = 429 [M + H]+.
1H NMR (500 MHz, CDCl3): δ = 1.05 (t, J = 7.5 Hz, 3 H), 2.24 (s,
3 H), 3.02 (d, J = 11.0 Hz, 1 H), 4.07 (qd, J1 = 7.5 Hz, 2J2 = 11.5 Hz,
2 H), 4.08 (d, J = 11.0 Hz, 1 H), 5.56 (s, 1 H), 5.97 (s, 1 H), 7.08 (d,
J = 8.5 Hz, 2 H), 7.28 (d, J = 8.5 Hz, 2 H).
Anal. Calcd for C20H19F3O7: C, 56.03; H, 4.47. Found: C, 55.64; H,
4.44.
19F NMR (470 MHz, CDCl3): δ = –84.08 (s, 3 F).
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2012, 44, 1686–1692